Watson Laboratories, Inc.
Cases where party is a Patent Asserter
Only "example" cases are shown here, for full list contact Shawn Miller
Cases where party is an Alleged Infringer
| # | Title | Civil Action Sort ascending | Venue | Filing Date | Asserter Categories | Patent Asserter | Alleged Infringer |
|---|---|---|---|---|---|---|---|
| 51 | Sunovion Pharmaceuticals Inc. v. Watson Pharmaceuticals Inc. et al | 1:12-cv-00993 | D.Del. |
|
|||
| 52 | Avanir Pharmaceuticals Inc. et al v. Watson Pharmaceuticals Inc. et al | 1:12-cv-00258 | D.Del. |
|
|||
| 53 | Avanir Pharmaceuticals Inc. et al v. Watson Pharmaceuticals Inc. et al | 1:12-cv-00258 | D.Del. |
|
|||
| 54 | Avanir Pharmaceuticals Inc. et al v. Watson Pharmaceuticals Inc. et al | 1:12-cv-00258 | D.Del. |
|
|||
| 55 | Merck & Cie et al v. Watson Laboratories Inc. | 1:12-cv-00161 | D.Del. |
|
|||
| 56 | Merck & Cie et al v. Watson Laboratories Inc. | 1:12-cv-00161 | D.Del. |
|
|||
| 57 | Merck & Cie et al v. Watson Laboratories Inc. | 1:12-cv-00161 | D.Del. |
|
|||
| 58 | Alcon Pharmaceuticals Ltd et al v. Watson Laboratories Inc. et al | 1:11-cv-00293 | D.Del. |
|
|||
| 59 | Alcon Pharmaceuticals Ltd et al v. Watson Laboratories Inc. et al | 1:11-cv-00293 | D.Del. |
|
|||
| 60 | Daiichi Sankyo Inc. et al v. Watson Pharmaceuticals Inc. et al | 1:11-cv-00074 | D.Del. |
|
|||
| 61 | Daiichi Sankyo Inc. et al v. Watson Pharmaceuticals Inc. et al | 1:11-cv-00074 | D.Del. |
|
|||
| 62 | Biovail Laboratories International SRL v. Watson Pharmaceuticals, Inc. et al | 1:10-cv-21241 | S.D.Fla. |
|
|||
| 63 | Allergan Inc. et al v. Watson Laboratories Inc.-Florida | 1:10-cv-00852 | D.Del. |
|
|||
| 64 | Allergan Inc. et al v. Watson Laboratories Inc.-Florida | 1:10-cv-00852 | D.Del. |
|
|||
| 65 | Allergan Inc. et al v. Watson Laboratories Inc.-Florida | 1:10-cv-00852 | D.Del. |
|
|||
| 66 | Allergan Inc. et al v. Watson Laboratories Inc.-Florida | 1:10-cv-00852 | D.Del. |
|
|||
| 67 | Cephalon Inc. et al v. Watson Pharmaceuticals Inc. et al | 1:08-cv-00330 | D.Del. |
|
|||
| 68 | Cephalon Inc. et al v. Watson Pharmaceuticals Inc. et al | 1:08-cv-00330 | D.Del. |
|
|||
| 69 | Wyeth v. Watson Laboratories Inc. et al | 1:08-cv-00145 | D.Del. |
|
|||
| 70 | In Re: Rivastigmine Patent Litigation | 1:05-md-01661 | S.D.N.Y. |
|
|||
| 71 | In Re: Rivastigmine Patent Litigation | 1:05-md-01661 | S.D.N.Y. |
|
|||
| 72 | In Re: Rivastigmine Patent Litigation | 1:05-md-01661 | S.D.N.Y. |
|
|||
| 73 | In Re: Rivastigmine Patent Litigation | 1:05-md-01661 | S.D.N.Y. |
|
|||
| 74 | In Re: Rivastigmine Patent Litigation | 1:05-md-01661 | S.D.N.Y. |
|
|||
| 75 | Pfizer Inc. et al v. Watson Pharmaceuticals, Inc. et al | 1:04-cv-05212 | S.D.N.Y. |
|
|||
| 76 | Pfizer Inc. et al v. Watson Pharmaceuticals, Inc. et al | 1:04-cv-05212 | S.D.N.Y. |
|
|||
| 77 | Pfizer Inc. et al v. Watson Pharmaceuticals, Inc. et al | 1:04-cv-05212 | S.D.N.Y. |
|